These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 26944323

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH, Dai ZK, Wu BN, Yeh JL, Chai CY, Chu KS, Liu CP, Chen IJ.
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [Abstract] [Full Text] [Related]

  • 7. The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin.
    Mixcoatl-Zecuatl T, Flores-Murrieta FJ, Granados-Soto V.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):87-95. PubMed ID: 16438951
    [Abstract] [Full Text] [Related]

  • 8. Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.
    Kuo KK, Wu BN, Liu CP, Yang TY, Kao LP, Wu JR, Lai WT, Chen IJ.
    J Lipid Res; 2015 Nov 15; 56(11):2070-84. PubMed ID: 26351364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle.
    Li F, De Godoy M, Rattan S.
    J Pharmacol Exp Ther; 2004 Mar 15; 308(3):1111-20. PubMed ID: 14711933
    [Abstract] [Full Text] [Related]

  • 13. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E, Hervias I, Goñi-Allo B, Lasheras B, Jordan J, Aguirre N.
    J Neurochem; 2009 Feb 15; 108(3):755-66. PubMed ID: 19187094
    [Abstract] [Full Text] [Related]

  • 14. KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.
    Wu BN, Chen HY, Liu CP, Hsu LY, Chen IJ.
    Int J Immunopathol Pharmacol; 2011 Feb 15; 24(4):925-39. PubMed ID: 22230399
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
    Wang J, Zhang LC, Lv YW, Ji Y, Yan XJ, Xue JP.
    Brain Res; 2008 May 13; 1209():1-7. PubMed ID: 18406400
    [Abstract] [Full Text] [Related]

  • 16. Aortic smooth muscle relaxants KMUP-3 and KMUP-4, two nitrophenylpiperazine derivatives of xanthine, display cGMP-enhancing activity: roles of endothelium, phosphodiesterase, and K+ channel.
    Wu BN, Chen IC, Lin RJ, Chiu CC, An LM, Chen IJ.
    J Cardiovasc Pharmacol; 2005 Nov 13; 46(5):600-8. PubMed ID: 16220066
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.
    Hernández-Pacheco A, Araiza-Saldaña CI, Granados-Soto V, Mixcoatl-Zecuatl T.
    Eur J Pharmacol; 2008 Oct 31; 596(1-3):70-6. PubMed ID: 18755181
    [Abstract] [Full Text] [Related]

  • 19. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation.
    Chung HH, Dai ZK, Wu BN, Yeh JL, Chai CY, Chu KS, Liu CP, Chen IJ.
    Vascul Pharmacol; 2010 Oct 31; 53(5-6):239-49. PubMed ID: 20870034
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.